Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Autoreactive Anti-Ro/SSA IgE To Determine Primary SjögRen's Syndrome's Disease Activity

NCT03003572 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Saint Etienne as lead sponsor.

NCT NCT03003572
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03003572 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Autoreactive Anti-Ro/SSA IgE To Determine Primary SjögRen's Syndrome's Disease Activity
Lead sponsor
Centre Hospitalier Universitaire de Saint Etienne
Phase
Observational
Overall status
Recruiting
Start date
March 27, 2018
Completion date
June 30, 2027
Enrollment
185 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

primary sjögren's syndrome